Viking Therapeutics stock jumps 120% after positive weight loss drug trial results – CNBC

Viking Therapeutics stock jumps 120% after positive weight loss drug trial results CNBC
Viking Therapeutics’ stock benefits as investors cheer weight-loss-drug results MarketWatch
Experimental weight-loss drug from Viking Therapeutics could rival Ozempic, Mounjaro The Washington Post

Brought to you by Google News. Read the rest of the article here.